For a full list of side effects, refer to the Trulicity medication guide. Bydureon BCise is a long-acting version of the GLP-1 agonist exenatide, used to help control blood sugar in people with type 2 ...

Medically reviewed by Isabel Casimiro, MD, PhD There are a variety of medications that have been developed in recent years ...

AstraZeneca announced that the EC green-lighted the new formulation of the once-weekly type-2 diabetes injection, which will be marketed as Bydureon BCise (exenatide 2mg prolonged-release suspension).

manage blood sugar levels in people with type 2 diabetes Yes* exenatide (Bydureon BCise) manage blood sugar levels in people with type 2 diabetes Yes* * Hair loss was not reported in the clinical ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

A phase 3 randomized controlled trial found no significant improvements with the GLP-1 exenatide in this population. Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo ...

A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

Vivani Medical has commenced the first-in-human, randomised trial, LIBERATE-1, by initiating screening and enrolment to assess the pharmacokinetic and safety profile of its exenatide NanoPortal ...

Bydureon BCise is a long-acting version of the GLP-1 agonist exenatide, used to help control blood sugar in people with type 2 diabetes. Bydureon BCise has been shown to reduce A1C by 1.5% to 1.9% ...